Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Isolation and Identification of Major Urinary Metabolites of Rifabutin in Rats and Humans

Ilya Utkin, Tatiana Koudriakova, Toni Thompson, Charles Cottrell, Eugenia Iatsimirskaia, John Barry, Paul Vouros and Nicholas Gerber
Drug Metabolism and Disposition August 1997, 25 (8) 963-969;
Ilya Utkin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tatiana Koudriakova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toni Thompson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Cottrell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eugenia Iatsimirskaia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Barry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Vouros
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Gerber
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The antimycobacterial drug rifabutin is extensively metabolized in humans and laboratory animals. About 40% of the dose is excreted in urine as unchanged drug, and lipophilic (extractable with 1-chlorobutane) and polar metabolites. Polar metabolites accounted for 59.1 ± 2.5% and 88.8 ± 4.4% of radioactivity in urine collected over 96 hr after intravenous administration of 25 and 1 mg/kg of [14C]rifabutin to Sprague-Dawley rats, respectively. After 48 hr, all urinary radioactivity consisted of polar metabolites. The most abundant polar metabolite, identified by electrospray ionization-MS, collision-induced dissociation-MS, and comparison of HPLC retention times with the synthetic standard, wasN-isobutyl-4-hydroxy-piperidine. Lipophilic metabolites accounted for <20% of urinary radioactivity. Major lipophilic metabolites, 25-O-deacetyl-rifabutin, 27-O-demethyl-rifabutin, 31-hydroxy-rifabutin, 32-hydroxy-rifabutin, and 20-hydroxy-rifabutin were isolated from both human and rat urine by HPLC and identified by electrospray ionization-MS, collision-induced dissociation-MS, and NMR spectrometry. In addition, two metabolites formed by the oxidation of theN-isobutyl-piperidyl group of rifabutin were found in the urine of rats, but not humans.

Footnotes

  • Send reprint requests to: Dr. Ilya Utkin, Department of Pharmacology, The Ohio State University, 333 West 10th Avenue, 5084 Graves Hall, Columbus, OH 43210.

  • Fourier transform-NMR spectra at 500 and 600 MHz were obtained at The Ohio State University Campus Chemical Instrument Center by Dr. C. E. Cottrell, using equipment funded by the National Institutes of Health Grants 1-S10-RR01458-01A1 and RR08299, and by the National Science Foundation Grant BIR-9921639. Mass spectra were obtained at the laboratory of Paul Vouros (Northeastern University) supported by the National Institutes of Health Grant IROICA 69390-01.

  • Abbreviations used are::
    po
    oral
    iv
    intravenous
    MRFA
    L-methionyl-arginyl-phenylalanyl-alanine
    TEA
    triethylamine
    RT
    retention time
    ESI-MS
    electrospray ionization-mass spectrometry
    CID-MS
    collision-induced dissociation-mass spectrometry
    COSY
    correlated spectroscopy
    HMQC
    heteronuclear correlation through multiple quantum coherence
    • Received December 4, 1996.
    • Accepted April 24, 1997.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition
Vol. 25, Issue 8
1 Aug 1997
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Isolation and Identification of Major Urinary Metabolites of Rifabutin in Rats and Humans
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Isolation and Identification of Major Urinary Metabolites of Rifabutin in Rats and Humans

Ilya Utkin, Tatiana Koudriakova, Toni Thompson, Charles Cottrell, Eugenia Iatsimirskaia, John Barry, Paul Vouros and Nicholas Gerber
Drug Metabolism and Disposition August 1, 1997, 25 (8) 963-969;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Isolation and Identification of Major Urinary Metabolites of Rifabutin in Rats and Humans

Ilya Utkin, Tatiana Koudriakova, Toni Thompson, Charles Cottrell, Eugenia Iatsimirskaia, John Barry, Paul Vouros and Nicholas Gerber
Drug Metabolism and Disposition August 1, 1997, 25 (8) 963-969;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Role of Human MSRA on Sulindac Activation
  • Determination of Acyl-, O-, and N-Glucuronide
  • Uptake as the RDS in Pevonedistat Hepatic Clearance
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics